Although the usage of recombinant hepatitis B virus surface (HBsAg) protein
Although the usage of recombinant hepatitis B virus surface (HBsAg) protein vaccine has successfully reduced global hepatitis B infection there are still a number of vaccine recipients who do not develop detectable antibody responses. original HBs-L DNA vaccine the HBs-L(T) DNA vaccine improved secretion in cultured mammalian cells and generated significantly enhanced HBsAg-specific antibody and … [Read more…]